Skip to Content

Naltrexone Pregnancy and Breastfeeding Warnings

Naltrexone is also known as: Depade, Revia, Vivitrol

Naltrexone Pregnancy Warnings

Naltrexone has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of an embryocidal effect when given in doses approximately 30 to 60 times the human therapeutic dose. There are no adequate and controlled study data in human pregnancy. Naltrexone is only recommended for use during pregnancy when benefit outweighs risk.

See references

Naltrexone Breastfeeding Warnings

Naltrexone and 6-beta-naltrexol are excreted into human milk. The effects on the nursing infant are unknown. The manufacturer recommends that due to the potential for tumorigenicity shown for naltrexone in animal studies, and for the potential of serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. ReVia (naltrexone)." DuPont Pharmaceuticals, Wilmington, DE.

References for breastfeeding information

  1. "Product Information. ReVia (naltrexone)." DuPont Pharmaceuticals, Wilmington, DE.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.